KIAA1524 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.456200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.503600E-01
Normal-vs-Stage2
7.072800E-01
Normal-vs-Stage3
4.126000E-01
Normal-vs-Stage4
7.346200E-01
Stage1-vs-Stage2
3.722800E-01
Stage1-vs-Stage3
4.068600E-01
Stage1-vs-Stage4
4.121800E-01
Stage2-vs-Stage3
1.507810E-01
Stage2-vs-Stage4
5.524600E-01
Stage3-vs-Stage4
2.951200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.827600E-01
Normal-vs-AfricanAmerican
6.741000E-01
Normal-vs-Asian
2.902000E-01
Caucasian-vs-AfricanAmerican
8.323000E-01
Caucasian-vs-Asian
2.196000E-01
AfricanAmerican-vs-Asian
4.414200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.863400E-01
Normal-vs-Female
7.432400E-01
Male-vs-Female
4.152800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.182600E-01
Normal-vs-Age(41-60Yrs)
9.419200E-01
Normal-vs-Age(61-80Yrs)
4.947600E-01
Normal-vs-Age(81-100Yrs)
7.578200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.680600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.027600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.947600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.860300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.595800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.647000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.808800E-01
Normal-vs-Daily Drinker
4.236400E-01
Normal-vs-Weekly Drinker
7.177000E-01
Normal-vs-Occasional Drinker
9.235200E-01
Normal-vs-Social Drinker
8.259800E-01
Non Drinker-vs-Daily Drinker
6.823000E-01
Non Drinker-vs-Weekly Drinker
7.458400E-01
Non Drinker-vs-Occasional Drinker
4.082000E-01
Non Drinker-vs-Social Drinker
5.376800E-01
Daily Drinker-vs-Weekly Drinker
4.886000E-01
Daily Drinker-vs-Occasional Drinker
2.532200E-01
Daily Drinker-vs-Social Drinker
3.232600E-01
Weekly Drinker-vs-Occasional Drinker
6.767600E-01
Weekly Drinker-vs-Social Drinker
8.020400E-01
Occasional Drinker-vs-Social Drinker
8.500000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.568800E-01
Normal-vs-Grade 2
9.861200E-01
Normal-vs-Grade 3
8.044600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.586800E-04
Grade 1-vs-Grade 3
1.391690E-04
Grade 1-vs-Grade 4
7.568800E-01
Grade 2-vs-Grade 3
2.025600E-01
Grade 2-vs-Grade 4
9.861200E-01
Grade 3-vs-Grade 4
8.044600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.829600E-01
Normal-vs-NonDiabetic
6.092800E-01
Diabetic-vs-NonDiabetic
2.801600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.278800E-01
Normal-vs-NoPancreatitis
5.674800E-01
Pancreatitis-vs-NoPancreatitis
9.183600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.643600E-01
Normal-vs-N1
6.904400E-01
N0-vs-N1
6.851800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.244200E-01
Normal-vs-TP53-NonMutant
4.411800E-01
TP53-Mutant-vs-TP53-NonMutant
7.73670000000504E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
